PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-09-27

Date Title Company
27-Sep-2024 Call for Speakers: Upcoming Careers Event with Future Biotechnologists Future Biotechnologists
27-Sep-2024 Hyivy Health Secures $2M Seed to Unlock New Model for Treating Pelvic Pain AccessWire
27-Sep-2024 Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #3 AccessWire
27-Sep-2024 Introducing Compassion Center Austin: Pioneering Natural Wellness Solutions Through the Texas Compassionate Use Program (TCUP) AccessWire
27-Sep-2024 Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion Newswire
27-Sep-2024 Humaneva Group Secures Major US Private Equity Investment to Accelerate Global Clinical Research Market Expansion AccessWire
27-Sep-2024 MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 Newswire
27-Sep-2024 MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 AccessWire
27-Sep-2024 Original-Research: Sernova Corp (von First Berlin Equity Research GmbH) Sernova Corp
27-Sep-2024 CF AMR Syndicate Announces First Awardees of £3m Collaborative Drug Discovery Programme Medicines Discovery Catapult
27-Sep-2024 Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation Medicines Discovery Catapult
27-Sep-2024 Diabetic Gastroparesis Treatment Market: Rising Demand Sparks Innovation and Research Pristine Market Insights
27-Sep-2024 Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval SYNBIOTIC SE
27-Sep-2024 SmartHMS Revolutionizes Healthcare Management with Its Advanced SMARTHMIS Software SMARTHMS & Solutions Private Limited
27-Sep-2024 CD Genomics Launches PacBio SMRT Sequencing Services to Revolutionize Genomic Research CD Genomics
27-Sep-2024 CD Genomics Introduces CircRNA Sequencing Service to Enhance Genomic Research CD Genomics
27-Sep-2024 Formycon and Fresenius Kabi receive European Commission approval for FYB202/Otulfi® (ustekinumab) for the treatment of serious inflammatory diseases Formycon AG
27-Sep-2024 Hemogenyx Pharmaceuticals PLC Announces Half-year Report AccessWire
27-Sep-2024 enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering AccessWire